# Luminary Therapeutics, Inc. — Form D

Luminary Therapeutics, Inc. of Minneapolis, MN, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-04. The offering totals $1.5M, of which $375K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-11-04
- Form: D
- Accession: 0001437749-21-025255
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $375K
- Remaining: $1.1M
- Investors: 3
- Date of first sale: 2021-10-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-419885

## Issuer

- Name: Luminary Therapeutics, Inc.
- CIK: 0001793860
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 1200 Washington Avenue South, Minneapolis, MN, 55415
- Phone: 612-309-7653

## Officers, directors & promoters (18)

| Name | Role | Location |
| --- | --- | --- |
| Jim Haymaker | Director | Minneapolis, MN |
| David Largaespada | Executive Officer | Minneapolis, MN |
| Branden Moriarity | Director | Minneapolis, MN |
| Mark Chance | Director | Minneapolis, MN |
| Tracey Lodie | Director | Minneapolis, MN |
| James Haymaker | Director | Minneapolis, MN |
| James Haymaker | Promoter | Minneapolis, MN |
| John Wells | Director | Minneapolis, MN |
| Jeff Ross | Director | Eden Prairie, MN |
| Jeff Liter | Director | Minneapolis, MN |
| Jeff Liter | Executive Officer | Minneapolis, MN |
| Jeff Liter | Promoter | Minneapolis, MN |
| David Largaespada | Director | Minneapolis, MN |
| David Largaespada | Promoter | Minneapolis, MN |
| Alexander Naydich | Director | Minneapolis, MN |
| John Hurley | Executive Officer | Minneapolis, MN |
| Peter Kosa | Director | Minneapolis, MN |
| George Cox | Director | Minneapolis, MN |

## Other filings by this issuer (7)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-11-05](https://search.stillhousedata.com/formd/0001437749-25-033325) | D | $12.4M | $1.4M |
| [2025-01-08](https://search.stillhousedata.com/formd/0001437749-25-000739) | D | $5.9M | $5.2M |
| [2025-01-08](https://search.stillhousedata.com/formd/0001437749-25-000736) | D/A | $5.5M | $5.2M |
| [2023-08-03](https://search.stillhousedata.com/formd/0001437749-23-021823) | D/A | $3.5M | $2.4M |
| [2023-01-11](https://search.stillhousedata.com/formd/0001437749-23-000883) | D | $2.8M | $2.2M |
| [2021-02-09](https://search.stillhousedata.com/formd/0001437749-21-002282) | D | $1.0M | $825K |
| [2019-11-14](https://search.stillhousedata.com/formd/0001437749-19-022844) | D | $1.5M | $1.5M |

## More

- [CIK 1793860 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1793860&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001437749-21-025255.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.